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INTRODUCTION 
Azole antifungals, including clotrimazole, act as an 
inhibitor to the fungal ergosterol synthetic pathway. 
Ergosterol is an essential compound for fungal cell 
wall integrity and requires that the C-14 methyl group 
of sterol to be removed if it is to maintain its integrity 
and normal functionality. Azole antifungals target the 
haeme protein, which is an active catalytic site of 14-
α-demethylase (CYP51) enzyme that catalyses 14-α-
demethylation of lanosterol in the ergosterol 
synthetic route. The inhibition of 14-α-demethylase 
enzyme leads to the accumulation of demethylated 
compounds, hence results in the death of fungal cell 
[1 - 3]. Clotrimazole is, one of the first generations of 
azole drugs, was first introduced by Bayer Ag 
(Germany) in 1967. Since that time this compound 
has been extensively studied. Clotrimazole has a 
broad spectrum of activity and is effective against 
Candida and Aspergillus species [4, 5].  
As antifungal resistance develops in fungi and other 
factors occur that affect the result of fungal infection 
treatment, scientists invent new antifungals. A 
number of structure-activity relationship studies of 
antifungal agents have been conducted over the past 
years. The main target of azole antifungals is CYP51 
(14-α-demethylase) of p450 enzymes and many 
studies focused on the computer aided structure 
modelling of this enzyme in relation to the activity of  
antifungals. Some structure-activity relationship 
studies of azole derivatives with the aid of molecular 
modelling of the CYP51 enzyme active site and the 
substrate binding mode suggest that conjugated 
aromatic moieties, including biphenyl and 
pyrrolylphenyl residues, confer better antifungal 
activity due to the favourable steric interaction within 
the enzyme’s active site cavity. Also, if an electron 
withdrawing group is placed in the para position of 
the phenyl group, then antifungal activity was 
increased [6]. In this study we aimed to design novel 




General: All reactions were conducted under 
nitrogen. Solvent concentration was performed on a 
Buchi rotary evaporator R-210. Flash column 
chromatography was conducted on silica 40-60 µ, 60 
Е with ethyl acetate and petrol as eluent unless 
specified otherwise. Melting points were determined 
by a Stuart SMP11 apparatus. IR spectra were 
obtained on a Varian 800 FT-IR. 1H and 13C NMR 
spectra were obtained on a BRUKER AVANCE-300 and 
a JEOL ECS-400. Mass spectra were recorded on a 
Waters LCT-Premier ESI high resolution mass 
spectrometer.  
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Preparation of (2-chlorophenyl)diphenylmethanol 
(2): Bromobenzene (1.6 g, 10.5 mmol) was added to 
magnesium turnings (0.25 g, 10.5 mmol). The reaction 
mixture was stirred at reflux and then at room 
temperature for a further 6 hours. Ketone (1) (1.5 g,   
7 mmol) was added and the reaction mixture was left 
stirring at room temperature for overnight. The 
reaction mixture was quenched with saturated 
ammonium chloride solution (30 mL). The aqueous 
layer was separated. Combined organic layers were 
washed with water and dried over MgSO4 and then 
removed. The crude yellow oily mass obtained was 
purified by flash chromatography to give 0.75 g of 
alcohol (2) (36% yield) as white crystals. mp 83-850C 
(lit 83 0C)[7]; Rf = 0.45; IR (neat) νmax/cm
-1 3566, 3058, 
1466, 1010; 1H NMR (300 MHz, CDCl3) δ (ppm): 7.40 
(dd, 1H, J = 1.6, 8.8 Hz), 7.24-7.35 (m, 11H), 7.01 (dt, 
1H, J = 1.2, 6.3 Hz), 6.70 (dd, 1H, J = 1.5, 6.3 Hz), 4.46 
(s, 1H); 13C NMR (75 MHz, CDCl3) δ (ppm): 145.6, 
143.8, 133.3, 131.4, 131.3, 128.9, 127.9, 127.7, 127.2, 




1H-imidazole (4): Thionyl chloride (0.82 g, 6.9 mmol) 
was added into a solution of alcohol (2) (0.69 g, 2.3 
mmol) and the mixture stirred at 0 0C for 1 hour. The 
reaction mixture was left at reflux stirring for 
overnight. The organic solvent was evaporated and 
the residue washed with acetonitrile (2 x 20 mL) to 
afford compound (3) as an yellow oily mass that was 
submitted for the further reaction directly without 
purification and structure elucidation. Imidazole (0.3 
g, 4.4 mmol) with Et3N (0.6 g, 6.6 mmol) was added to 
the solution of compound (3) (0.7 g, 2.2 mmol). The 
reaction mixture was left at room temperature at 
reflux stirring for 72 hours. The organic solvent was 
removed and EtOAc (20 mL) with water (20 mL) was 
added to the residue. The aqueous layer was 
extracted with EtOAc (2 x 20 mL). Combined organic 
layers were washed with water and dried over MgSO4 
prior to evaporation. The crude product was purified 
by flash chromatography to afford 0.69 g of 
compound (4) as a white crystal (yield 91%). mp 130-
133 0C; Rf = 0.37; IR (neat) νmax/cm
-1 3064, 1489, 1443, 
1210, 750; 1H NMR (300 MHz, CDCl3) δ (ppm): 7.48 (s, 
1H), 7.41-7.44 (m 1H), 7.32-7.37 (m, 7H), 7.26-7.29 
(m, 1H), 7.19-7.23 (m, 4H), 7.07 (s, 1H), 6.92 (dd, 1H, J 
= 1.5, 6.3 Hz), 6.76 (s, 1H); 13C NMR (100 MHz, CDCl3) 
δ (ppm): 151.1, 150.5, 148.9, 144.5, 140.3, 138.0, 
137.7, 137.3, 135.5, 135.2, 135.1, 133.8, 127.0, 68.9; 
m/z calcd for C19H14Cl [M-Imid]
+ 277.0784, found 
277.0780.  
Preparation of [1,1'-biphenyl]-4-yl(phenyl)methanol 
(6): Bromobenzene (3.14 g, 20 mmol) was added to 
magnesium turnings (0.48 g, 20 mmol). The reaction 
mixture was stirred at reflux, then at room 
temperature for an additional 4 hours. Aldehyde (5) 
(1.82 g, 10 mmol)  was  added  to the reaction and the  
mixture left stirring at room temperature for 
overnight. The reaction mixture was quenched with a 
saturated ammonium chloride solution (40 mL). The 
aqueous layer was separated and extracted with Et2O. 
The combined organic layers were washed with water 
then dried over MgSO4 and then removed. The crude 
yellow crystals obtained were purified by flash 
chromatography to give 1.34 g of Alcohol (6) (73% 
yield) as weak yellow crystals. mp 79-83 0C (lit 90-92 
0C)[8]; Rf = 0.21; IR (neat) νmax/cm
-1 3256, 3028, 1487, 
1016; 1H NMR (300 MHz, CDCl3) δ (ppm): 7.57-7.60 
(m, 3H), 7.28-7.49 (m, 10H), 5.92 (d, 1H, J = 3.0 Hz), 
2.25 (d, 1H, J = 3.0 Hz); 13C NMR (100 MHz, CDCl3) δ 
(ppm): 143.8, 142.9, 140.8, 140.5, 128.8, 128.6, 127.7, 
127.4, 127.3, 127.2, 127.0, 126.6, 76.1; m/z calcd for 
C19H15 [M-OH]
+ 243.1174, found 243.1165.  
Preparation of [1,1'-biphenyl]-4-yl(phenyl)
methanone (7): Solution of alcohol (6) (1 g, 3.8 mmol) 
was added to pyridinium chlorochromate (1.2 g, 5.7 
mmol) and celite (4 g) and the reaction mixture 
stirred at reflux for 3 hours at room temperature. The 
reaction mixture was filtered and the collected 
organic solution was dried over MgSO4 and 
concentrated to afford 1.11 g (100% yield) of ketone 
(7) as a white crystal. mp 87-90 0C (lit 99-100 0C) [9], 
Rf = 0.47; IR (neat) νmax/cm
-1 3052, 1643, 1597, 1445; 
1H NMR (400 MHz, CDCl3) δ (ppm): 8.58-8.62 (m, 2H), 
8.51-8.55 (m, 2H), 8.35-8.38 (m, 2H), 8.21-8.31 (m, 
3H) 8.06-8.13 (m, 4H), 7.97-8.02 (m, 1H); 13C NMR 
(100 MHz, CDCl3) δ (ppm): 196.4, 145.3, 140.0, 137.8, 
136.3, 132.4, 130.8, 130.1, 129.0, 128.4, 128.2, 127.4, 
127.0; m/z calcd for C19H15O [M]
+ 259.1123, found 
259.1130.  
Preparation of [1,1'-biphenyl]-4-yl(4-fluorophenyl)
(phenyl)methanol (8): Solution of 4-fluoro-1-
bromobenzene (0.9 g, 5.4 mmol) was added to 
magnesium turnings (0.13 g, 5.4 mmol). The reaction 
mixture was stirred at reflux, then at room 
temperature for further 6 hours. A solution of ketone 
(7) (0.7 g, 2.7 mmol) was added and the reaction 
mixture left stirring at room temperature for 
overnight. The reaction mixture was quenched with a 
saturated ammonium chloride solution (30 mL). The 
aqueous layer was separated and extracted with Et2O 
(2 x 20 mL). The combined organic layers were 
washed,with water then dried over MgSO4 and 
evaporated. Purification of the crude product was 
conducted by flash chromatography to give 0.73 g of 
alcohol (8) as a colourless oil (76% yield). Rf = 0.35; IR 
(neat) νmax/cm
-1 3477, 3030, 1600, 1506, 1224, 1158; 
1H NMR (400 MHz, CDCl3) δ (ppm): 8.34-8.37 (m, 2H), 
8.26-8.30 (m, 2H), 8.11-8.16 (m, 2H), 7.95-8.05        
(m, 10H), 7.54-7.62 (m, 2H) 2.91 (s, 1H); 13C NMR (100 
MHz, CDCl3) δ (ppm): 179.1, 176.1, 158.6, 157.2, 
153.6, 150.8, 150.3, 137.5, 137.4, 136.3, 135.8, 135.7, 
135.3, 135.1, 134.7, 134.5, 134.1, 133.6, 118.7, 118.5, 
77.2; m/z calcd for C25H18F [M-OH]
+ 337.1393, found 
337.1401.  
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Preparation of 1-([1,1'-biphenyl]-4-yl(4-fluorophenyl)
(phenyl)methyl)-1H-imidazole (10): Thionyl chloride 
(0.7g, 6 mmol) with dimethyl formamide (0.1 mL) was 
added to a solution of alcohol (8) (0.7 g, 2 mmol) in 
anhydrous dichloromethane (20 mL) and the mixture 
stirred at 00C for 1 hour. The reaction mixture was left 
at 400C at reflux stirring for overnight. The organic 
solvent was evaporated under reduced pressure and 
the residue was washed with acetonitrile (2 x 20 mL) 
to afford compound (9) as an yellow oily mass and 
was submitted for the further reaction immediately 
with no purification and the structure elucidation. A 
solution of imidazole (0.2 g, 3.5 mmol) with Et3N 
(0.5g, 5.2 mmol) was prepared in anhydrous 
acetonitrile (20 mL) at 00C and slowly added to a 
solution of compound (10) (0.7g, 1.7 mmol) in 
anhydrous acetonitrile (20 mL). The reaction mixture 
was left at 800C at reflux stirring for 72 hours. The 
organic solvent was evaporated and EtOAc (20 mL) 
with water (20 mL) was added to the residue. The 
aqueous layer was extracted with EtOAc (2 x 20 mL). 
The combined organic layers were washed with brine 
solution (30 mL) then dried over MgSO4 prior to 
evaporation. The crude product was purified by flash 
chromatography to afford 0.3g of compound (10) as a 
white crystal (47% yield). mp 97-99 0C; Rf = 0.38; IR 
(neat) νmax/cm
-1 3031, 1735, 1600, 1507, 1233, 1164; 
1H NMR (400 MHz, CDCl3) δ (ppm): 8.17-8.24 (m, 4H), 
8.11 (s, 1H), 8.01-8.06 (m, 2H), 7.91-7.96 (m, 4H), 7.66
-7.73 (m, 6H), 7.62 (s, 1H), 7.49-7.57 (m, 2H), 7.30 (s, 
1H); 13C NMR (100 MHz, CDCl3) δ (ppm): 179.3, 176.2, 
152.9, 151.6, 151.2, 149.9, 148.7, 148.0, 139.6, 139.5, 
137.7, 136.2, 135.7, 135.4, 135.3, 134.7, 133.9, 133.4, 
127.1, 119.0, 118.7, 68.3; m/z calcd for C25H18F [M-
Imid]+ 337.1393, found 337.1401.  
Antifungal activity evaluation of compounds 4 and 
10: Test samples (10 mg) were dissolved in DMSO (1 
mL) to prepare 1 mg/mL solutions, respectively. Test 
microorganisms E.coli, M.luteus and yeast were 
suspended in a Ringer solution (1.5 mL) within an 
eppendorf tube (1.5 mL) using an inoculation loop. UV 
spectra were calibrated with McFarland standard 
solution No. 0.5 (described below). The suspension 
was diluted until the absorbance of UV spectroscopy 
indicated approximately 0.1. Test bacteria and an 
yeast were inoculated using sterile cotton-wool swab 
on Mueller Hinton agar (MHA) and potato dextrose 
agar (PDA) plates (90 mm), respectively. Solutions of 
test compounds were placed on blank disk filter  
papers (7 mm) and the disks were transferred onto 
plates. Bacteria and yeast were allowed to grow 24 
and 48 hours, respectively. Inhibition zones of test 
samples and standard drug were measured in 
millimetre.  
McFarland Standard No. 0.5: 
1.0 % Barium chloride (ml) 0.05 
1.0 % Sulfuric acid (ml) 9.95 
Approx. cell density (1 x 108 CFU ml-1) 1.5 
% Transmittance 74.3 
Absorbance 0.132 
 
RESULTS AND DISCUSSION 
The antifungal agent clotrimazole (4) was synthesised 
in three steps (Scheme-1).  
Scheme 1. Synthesis of clotrimazole 
The synthesis started with commercially available 
ketone (1) and preparation of alcohol (2) was 
successful (36% yield). Chlorinated compound (3) has 
been prepared and submitted for further substitution 
reaction immediately without purification, 
characterisation and the structure elucidation due to 
instability of chlorinated compound (3) as this was 
previously reported[10]. Characterisation of 
clotrimazole (4) was achieved with spectral analysis 
including 2D (1H-1H) COSY NMR, MS and IR to confirm 
the structure.   
Synthesis of a novel azole biphenyl derivative (10) was 
carried out in 5 steps linear synthetic route (Scheme 
2). The overall yield of the entire synthesis was low at 
26 %. There was no previous analytical data of the 
structure of compound (10), the spectral analysis 
supported the formation of a new compound.  
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The antifungal activity of the biphenyl derivative (10, 
Z-6.1) together with clotrimazole (Z-1.6) was 
determined using Kirby-Bauer agar diffusion method. 
Fluconazole - 25 µg (FCN) standard test sample and a 
DMSO dissolved disk were used as control agents.  
Similar inhibition zones were observed for the 
biphenyl derivative (10) and DMSO dissolved disks  
excluding clotrimazole and fluconazole on yeast after 
growing 24 hours (Figure 1, A). This result was found 
to be related to solvent we used to dissolve our test 
samples for the bioassay and therefore we decided to 
grow yeast further 24 hours. After growing 48 hours, 
different inhibition zones were observed as indicated 
in Table 1 (Figure 1, B).  
Scheme 2. Synthetic route of the biphenyl derivative (10)  
A                                                                                  B 
Fig. 1. Yeast plates. A - after 24 hours, B - after 48 hours  
 
Table 1. Inhibition zones on an yeast plate  
Samples Concentration (µg) 
Inhibition zone (mm) 
24 hours after 48 hours after 
Z-6.1 
50 15 11 
100 15 11 
200 17 13 
Z-1.6 100 31 27 
FCN 25 23 0 
DMSO - 13 0 
The novel azole derivative (10) had the highest 
activity at 200 µg, where as the clotrimazole showed 
more activity at twice as less concentration compared 
to the novel azole. Moreover, the compound (10) was 
not active against both M.luteus and E.coli after 24 
hours of growing.  
CONCLUSIONS 
We successfully synthesised clotrimazole (4) and a 
novel biphenyl derivative as 1-([1,1'-biphenyl]-4-yl(4-
fluorophenyl)(phenyl)methyl)-1H-imidazole (10) 
through multistep synthesis. The overall yield of novel 
clotrimazole derivative (10) was comparably low at 26  
31
%  We found that the compound (10) was active 
against an yeast but less than compound (4). DMSO 
was believed not to be an appropriate solvent for 
antifungal testing by virtue of its physical property 
(high boiling point). Therefore, it was impossible to 
test compounds in higher concentration due to 
limited absorption of the disks we used. The newly 
synthesised compound (10) has been proven not to 
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